Zhao Liu

702 total citations · 1 hit paper
43 papers, 446 citations indexed

About

Zhao Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhao Liu has authored 43 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Zhao Liu's work include Cancer Cells and Metastasis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Renal cell carcinoma treatment (4 papers). Zhao Liu is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Renal cell carcinoma treatment (4 papers). Zhao Liu collaborates with scholars based in China, Japan and United States. Zhao Liu's co-authors include Zhen Zhang, Weijun Peng, Xin Cheng, Hongli Li, Lemei Zhu, Jianhua Huang, Di Zhao, Abhik Bandyopadhyay, Norio Uemura and Hiromitsu Hayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Zhao Liu

42 papers receiving 444 citations

Hit Papers

Quercetin: A promising therapy for diabetic encephalopath... 2023 2026 2024 2025 2023 40 80 120

Peers

Zhao Liu
Bong Jun Cho South Korea
C.-W. Chi Taiwan
Shafi Ahmed United Kingdom
Peng Meng China
Yuan Dong China
Zhao Liu
Citations per year, relative to Zhao Liu Zhao Liu (= 1×) peers Vahid Vahedian

Countries citing papers authored by Zhao Liu

Since Specialization
Citations

This map shows the geographic impact of Zhao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Liu more than expected).

Fields of papers citing papers by Zhao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Liu. The network helps show where Zhao Liu may publish in the future.

Co-authorship network of co-authors of Zhao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Liu. A scholar is included among the top collaborators of Zhao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Liu. Zhao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Anqi, Zhao Liu, Xinmei Zhou, et al.. (2024). Real-World Treatment Adherence to Smoking Cessation Medications and Association with Treatment Outcome — 27 Centers, China, 2017–2022. China CDC Weekly. 6(22). 522–529. 1 indexed citations
2.
Li, Liya, Xinsheng Zhang, Xiang Huang, et al.. (2024). A cross-sectional survey study on the correlation analysis of nutritional status and intestinal flora in patients with esophageal cancer. Frontiers in Nutrition. 11. 1424039–1424039. 3 indexed citations
3.
Chen, Shiliang, et al.. (2024). Pan-Cancer Screening and Validation of CALU’s Role in EMT Regulation and Tumor Microenvironment in Triple-Negative Breast Cancer. Journal of Inflammation Research. Volume 17. 6743–6764. 2 indexed citations
4.
Liu, Zhao, et al.. (2024). Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19. Saudi Medical Journal. 45(4). 341–348.
5.
Li, Xin, et al.. (2022). Integrative Analysis of Peripheral Blood Indices for the Renal Sinus Invasion Prediction of T1 Renal Cell Carcinoma: An Ensemble Study Using Machine Learning-Assisted Decision-Support Models. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Lan, Chuan, Yo‐ichi Yamashita, Hiromitsu Hayashi, et al.. (2022). High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Annals of Surgical Oncology. 29(6). 3551–3564. 3 indexed citations
8.
Liu, Zhao, Hiromitsu Hayashi, Yoko Ogata, et al.. (2022). Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer. British Journal of Cancer. 128(5). 844–856. 19 indexed citations
9.
Yu, Fei, et al.. (2021). A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(10). 963–975. 2 indexed citations
10.
Hayashi, Hiromitsu, et al.. (2021). Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 700315–700315. 13 indexed citations
11.
Hayashi, Hiromitsu, Norio Uemura, Kazuki Matsumura, et al.. (2021). Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma. World Journal of Gastroenterology. 27(43). 7480–7496. 20 indexed citations
12.
Li, Wenjie, Xiaodi Liu, Zhao Liu, et al.. (2020). Prostate cancer: a risk factor for COVID-19 in males?. Medicine. 99(43). e22591–e22591. 5 indexed citations
13.
Hayashi, Hiromitsu, Norio Uemura, Zhao Liu, et al.. (2020). Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma. In Vivo. 34(5). 2845–2850. 5 indexed citations
14.
Chen, Kexin, et al.. (2020). Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer. Pathology - Research and Practice. 216(7). 153000–153000. 4 indexed citations
15.
Liu, Zhao, Shasha Qi, Yibing Fu, et al.. (2019). NUMB knockdown enhanced the anti-tumor role of cisplatin on ovarian cancer cells by inhibiting cell proliferation and epithelial-mesenchymal transition. Translational Cancer Research. 8(2). 379–388. 1 indexed citations
16.
Liu, Zhao. (2015). Laparoscopic pancreaticoduodenectomyviaa reverse-''V'' approach with four ports: Initial experience and perioperative outcomes. World Journal of Gastroenterology. 21(5). 1588–1588. 11 indexed citations
17.
Liu, Zhao, Abhik Bandyopadhyay, Nameer B. Kirma, et al.. (2015). Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells. PLoS ONE. 10(4). e0121136–e0121136. 22 indexed citations
19.
Liu, Zhao, et al.. (2012). Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells. Journal of Stem Cell Research & Therapy. 2(1). 1–8. 34 indexed citations
20.
Liu, Zhao. (2000). Experimental Study on Effects of L-OHP on Anti tumors. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026